FGF19 and Fabry disease: Serum levels of FGF-19 were assessed in 3 groups: 9 FD patients with GIS (FD GIS) carrying the previously identified polymorphisms, 8 FD patients without GIS (FD no GIS), and 15 healthy subjects (HS).